Please confirm that you are in the UK and are an Institutional Investor

ESG Viewpoint – COVID-19 and the pharmaceutical industry

How is the pharmaceutical industry responding to COVID-19?

Investor engagement: lessons from the Global Financial Crisis

How did the global financial crisis shape investor engagement?

Investor engagement: routes to escalation

Discover investor engagement escalation strategies.

Responsible investing: What does good engagement look like?

We consider what good investor engagement looks like.

The future of investor engagement

Discover what we believe will shape investor engagement this decade.

Investor engagement: crossing boundaries

Discover how investor engagement is crossing boundaries.

Investor engagement and COVID-19: The ‘S’ factor

Learn about the ‘S’ in ESG.

Investor engagement: Case studies

Discover three investor engagement case studies

ESG Viewpoint – Racial justice: the imperative for investor action

How should our industry address racial justice?

ESG Viewpoint: COVID-19 and labour-related impacts

The impacts of COVID-19 on labour issues

Investing with impact in mind

BMO Responsible Global Emerging Markets Equity Strategy ESG Profile and Impact Report 2020

BMO Responsible Global Equity Strategy ESG Profile and Impact Report 2020

This is our fifth annual report for this strategy, and in it we have taken the opportunity to refresh our SDG revenue alignment reporting.